AMIFOSTINE

氨磷汀

• 批准号: 7378997
• 负责人: MAHESH KUDRIMOTI
• 金额: $ 0.08万
• 依托单位: UNIVERSITY OF KENTUCKY
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-04-01 至 2007-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7378997
• 关键词: AMIFOSTINE

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The primary objective of this trial is to compare the incidence of grade 3/4 mucositis in patients receiving amifostine (Ethyol) while undergoing HYPERRADPLAT to that of the incidence of grade 3/4 mucositis previously reported in patients who received a single injection of IA cisplatin in UK studies.

该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者（PI）可能从另一个NIH来源获得主要资金，因此可以在其他CRISP条目中表示。所列机构为中心，不一定是研究者所在机构。本试验的主要目的是比较接受氨磷汀（Ethyol）同时接受HYPERRADPLAT的患者中3/4级粘膜炎的发生率与既往在英国研究中接受单次IA顺铂注射的患者中报告的3/4级粘膜炎的发生率。